
Ankeet Bhatt, MD, MBA, ScM, explains how prediction markets could threaten clinical trial integrity by undermining participant retention and trust.
New CDC recommendations on hepatitis B vaccination raise concerns over increased infections and healthcare costs, complicating public health efforts.
Unlike ever before, the current Health and Human Services (HHS) leadership has muddied the waters as it relates to the agency's longstanding intentions regarding access to vaccines for Americans.






